Anatomy Of RTSM Change Requests: How Modern Platforms Are Eliminating Delays

By Ryan Keane, Founder and CEO, Korio

In the high-stakes environment of clinical trials, agility is often sidelined by the technical debt of legacy systems. When a protocol shifts, many study teams are frustrated to find that even minor updates to their Randomization and Trial Supply Management (RTSM) software can trigger months of delays. This bottleneck isn’t just an inconvenience; it’s a systemic failure of outdated architecture.

The lag typically stems from a "custom-code" trap. Traditional providers often treat each study as a unique software build, requiring engineers to manually sift through thousands of lines of bespoke code just to assess the impact of a simple change. This results in a "shared resource queue" where your timeline is at the mercy of a vendor's staffing levels. Modernizing this process requires moving away from manual, person-dependent workflows and toward standardized, configurable platforms. By utilizing a unified architecture, teams can bypass the weeks spent on impact assessments and the months spent in the engineering queue. Shifting to an adaptable RTSM model ensures your system evolves at the speed of your science, rather than being anchored by the limitations of legacy software.